NICOLETTI, FERDINANDO

NICOLETTI, FERDINANDO  

SCIENZE BIOMEDICHE E BIOTECNOLOGICHE  

Mostra records
Risultati 1 - 20 di 393 (tempo di esecuzione: 0.034 secondi).
Titolo Data di pubblicazione Autore(i) File
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs 1-gen-2009 Nicoletti, Ferdinando; Conrad, D; Wang, A; Pieters, R; Mangano, KATIA DOMENICA; VAN HEECKEREN, A; White, Sk; Frincke, J; Reading, Cl; Auci, Dl; Stickney, D.
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson's Disease 1-gen-2012 Nicoletti, Ferdinando; Philippens, I; Fagone, P; Ahlem, Cn; Reading, Cl; Frincke, Jm; Auci, D. L.
5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice. 1-gen-2010 Nicoletti, Ferdinando; Auci, Dl; Mangano, KATIA DOMENICA; Flores Riveros, J; Villegas, S; Frincke, Jm; Reading, Cl; Offner, H.
A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice 1-gen-2007 Stosic Grujicic, Stanislava; Cvetkovic, Ivana; Mangano, KATIA DOMENICA; Fresta, Massimo; Maksimovic Ivanic, Danijela; Harhaji, Ljubica; Popadic, Dusan; Momcilovic, Miljana; Miljkovic, Djordje; Kim, Joseph; Al Abed, Yousef; Nicoletti, Ferdinando
A randomised, double blind, placebo-controlled trial on the effect of Fusidin in patients with newly diagnosed Type 1 diabetes: the FUSIDM tria 1-gen-2004 Conget, I; Aguilera, E; Pellitero, S; Naf, S; Bendtzen, K; Casamitjana, R; Gomis, R; Nicoletti, Ferdinando
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 1-gen-2015 Donia, Marco; Andersen, Rikke; Kjeldsen Julie, W; Fagone, Paolo; Munir, Shamaila; Nicoletti, Ferdinando; Andersen Mads, Hald; Thor Straten, Per; Svane Inge, Marie
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 1-gen-2014 Fagone, P; Mangano, KATIA DOMENICA; Mammana, S; Quattrocchi, C; Magro, Gaetano Giuseppe; Coco, Marinella; Imene, S; Di Marco, R; Nicoletti, Ferdinando
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 1-gen-2017 Donia, M; Harbst, K; van Buuren, M; Kvistborg, P; Lindberg, Mf; Andersen, R; Idorn, M; Munir Ahmad, S; Ellebæk, E; Mueller, A; Fagone, P; Nicoletti, F; Libra, M; Lauss, M; Hadrup, Sr; Schmidt, H; Andersen, Mh; Thor Straten, P; Nilsson, Ja; Schumacher, Tn; Seliger, B; Jönsson, G; Svane, I. M.
Advances in targeting signal transduction pathways. 1-gen-2012 Mccubrey, Ja; Steelman, Ls; Chappell, Wh; Sun, L; Davis, Nm; Abrams, Sl; Franklin, Ra; Cocco, L; Evangelisti, C; Chiarini, F; Martelli, Am; Libra, Massimo; Candido, S; Ligresti, G; Malaponte, G; Mazzarino, Maria Clorinda; Fagone, P; Donia, M; Nicoletti, Ferdinando; Polesel, J; Talamini, R; Basecke, J; Mijatovic, S; Maksimovic Ivanic, D; Milella, M; Tafuri, A; Dulinska Litewka, J; Laidler, P; D'Assoro, Ab; Drobot, L; Umezawa, K; Montalto, G; Cervello, M; Demidenko, Zn
Ageing: from inflammation to cancer. 1-gen-2018 Leonardi Giulia, Costanza; Accardi, Giulia; Monastero, R; Nicoletti, Ferdinando; Libra, Massimo.
Akt as a therapeutic target in cancer 1-gen-2008 Steelman, Ls; Stadelman, Km; Chappell, Wh; Horn, S; Bäsecke, J; Cervello, M; Nicoletti, Ferdinando; Libra, Massimo; Stivala, F; Martelli, Am; Mccubrey, Ja
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 1-gen-2021 Fagone, Paolo; Mangano, Katia; Di Marco, Roberto; Reyes-Castillo, Zyanya; Muñoz-Valle, José Francisco; Nicoletti, Ferdinando
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 1-gen-1999 Di Marco, R; Khademi, M; Wallstrom, E; Muhallab, S; Nicoletti, Ferdinando; Olsson, T.
Amniotic-derived peptide and uses thereof 1-gen-2006 Bakhutashvili, V; HALLER J., D; Bakhutashvili, I; Bakhutashvili, A; Nicoletti, Ferdinando; Thiry, M; Poncin,
An imidazoline compound completely counteracts interleukin-1 [beta] toxic effects to rat pancreatic islet [beta] cells 1-gen-2002 Papaccio, G; Nicoletti, Ferdinando; Pisanti, Fa; Galdieri, M; Bendtzen, K.
The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy 1-gen-2009 Dujmovic, I; Mangano, KATIA DOMENICA; Pekmezovic, T; Quattrocchi, C; Mesaros, S; Stojsavljevic, N; Nicoletti, Ferdinando; Drulovic, J.
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 1-gen-2006 Libra, Massimo; Mangano, KATIA DOMENICA; Anzaldi, M; Quattrocchi, C; Donia, M; DI MARCO, R; Signorelli, Salvatore; Scalia, Guido; Zignego, Al; DE RE, V; Mazzarino, Maria Clorinda; Nicoletti, Ferdinando
Androstene Hormones as regulators of Inflammation: role of Regulatory T Cells 1-gen-2007 Nicoletti, Ferdinando; Mangano, K.; Frincke, J.; Pieters, R.; Offner, H.; Auci, D.
Androsteneidiol ameliorates experimental autoimmune encephalomyelitis in mice and may limit relapses in patients with multiple sclerosis 1-gen-2010 Auci, D.; Nicoletti, Ferdinando; Mangano, K.; Reading, C.; Frincke, J.; Stickney, D.; Offner, H.
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine 1-gen-2017 Lupo, Gabriella; Nunzia, Caporarello; Melania, Olivieri; Martina, Cristaldi; Carla, Motta; Vincenzo, Bramanti; Avola, Roberto; Salmeri, Mario; Nicoletti, Ferdinando; Anfuso, CARMELINA DANIELA